Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies
Apply
Olutasidenib
A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step